Employees: NN (None)Legal category: 5470Size: PMECreation date: 2017-04-17 (9 years)Status: ActiveBusiness sector: Activités des sociétés holdingLocation: MARSEILLE (13003), Bouches-du-Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SPFPL DE PHARMACIENS D'OFFICINE DIP : revenue, balance sheet and financial ratios
SPFPL DE PHARMACIENS D'OFFICINE DIP is a French company
founded 9 years ago,
specialized in the sector Activités des sociétés holding.
Based in MARSEILLE (13003),
this company of category PME
shows in 2025 a net income positive of 43 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SPFPL DE PHARMACIENS D'OFFICINE DIP (SIREN 828750414)
Indicator
2025
2024
Revenue
N/C
N/C
Net income
42 666 €
42 317 €
EBITDA
-1 135 €
-1 360 €
Net margin
N/C
N/C
Revenue and income statement
In 2025, SPFPL DE PHARMACIENS D'OFFICINE DIP generates positive net income of 43 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2024-2025: 42 k€ -> 43 k€.
EBITDA (2025)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
-1 135 €
EBIT (2025)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
-1 135 €
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
42 666 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 11%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 90%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.5 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
10.97%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
90.115%
Repayment capacity (2025)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
0.503
Solvency indicators evolution SPFPL DE PHARMACIENS D'OFFICINE DIP
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2024
2025
Debt ratio
21.247
10.97
Financial autonomy
82.477
90.115
Repayment capacity
0.769
0.503
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
10.972025
2024
2025
Q1: 0.04
Med: 8.09
Q3: 54.01
Average
In 2025, the debt ratio of SPFPL DE PHARMACIENS D'OF... (10.97) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
90.11%2025
2024
2025
Q1: 21.27%
Med: 67.32%
Q3: 92.99%
Good
In 2025, the financial autonomy of SPFPL DE PHARMACIENS D'OF... (90.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
0.5 years2025
2024
2025
Q1: 0.0 years
Med: 0.19 years
Q3: 2.98 years
Average
In 2025, the repayment capacity of SPFPL DE PHARMACIENS D'OF... (0.50) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
Interest coverage (2025)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
-26.344
Liquidity indicators evolution SPFPL DE PHARMACIENS D'OFFICINE DIP
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2024
2025
Liquidity ratio
None
None
Interest coverage
-31.103
-26.344
Sector positioning
Interest coverage
-26.34x2025
2024
2025
Q1: -62.1x
Med: 0.0x
Q3: 0.0x
Average
In 2025, the interest coverage of SPFPL DE PHARMACIENS D'OF... (-26.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Positioning of SPFPL DE PHARMACIENS D'OFFICINE DIP in its sector
Comparison with sector Activités des sociétés holding
Valuation estimate
Indicative estimate only : the number of comparable transactions in this sector is limited (20 transactions).
This range of 17 014€ to 524 334€ is provided for information purposes only and requires in-depth analysis to be confirmed.
Estimated enterprise value2025
Indicative
17k€87k€524k€
87 628 €Range: 17 014€ - 524 334€
NAF 5 année 2025
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 20 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Activités des sociétés holding)
Compare SPFPL DE PHARMACIENS D'OFFICINE DIP with other companies in the same sector:
Frequently asked questions about SPFPL DE PHARMACIENS D'OFFICINE DIP
What is the revenue of SPFPL DE PHARMACIENS D'OFFICINE DIP ?
The revenue of SPFPL DE PHARMACIENS D'OFFICINE DIP is not publicly disclosed (confidential accounts filed with INPI).
Is SPFPL DE PHARMACIENS D'OFFICINE DIP profitable?
Yes, SPFPL DE PHARMACIENS D'OFFICINE DIP generated a net profit of 43 k€ in 2025.
Where is the headquarters of SPFPL DE PHARMACIENS D'OFFICINE DIP ?
The headquarters of SPFPL DE PHARMACIENS D'OFFICINE DIP is located in MARSEILLE (13003), in the department Bouches-du-Rhone.
Where to find the tax return of SPFPL DE PHARMACIENS D'OFFICINE DIP ?
The tax return of SPFPL DE PHARMACIENS D'OFFICINE DIP is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SPFPL DE PHARMACIENS D'OFFICINE DIP operate?
SPFPL DE PHARMACIENS D'OFFICINE DIP operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart